The clinical trials and studies for the development of new medications include:

• Pharmacokinetic studies (determination of pharmacokinetic parameters; bioavailability including bioequivalences for generic medications; metabolism and metabolite identification).
• Consulting on methodology for clinical trial protocols.
• Phase I and phase II efficacy and tolerability trials.
• Abuse liability evaluation of new medications (psychopharmacological profile, studies of preference and discrimination).